Chen, J., Li, B., Gan, Y., Li, P. (2026). TNFRSF17 as a complementary biomarker to PD-L1 for predicting the response to immunotherapy in urothelial bladder cancer. PLoS ONE. https://doi.org/10.1371/journal.pone.0346131